Landscapes / Targets
CD5
4 drugs act on CD5, in 4 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs4
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 14 Mar 2027Phase 1/2 trial completes | |||
| Next date | 14 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Jun 2027Phase 1/2 trial completes | |||
| Next date | 14 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | B2 Thymoma, Thymic Carcinoma | ||||
| Open drug page | |||||
— |
Phase 2 | Feb 2028Phase 2 trial completes | |||
| Next date | Feb 2028 · Phase 2 trial completes | ||||
| Also tested for | Lymphoma, T-Cell | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Mar 2027Phase 1 trial completes | |||
| Next date | 31 Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | T-ALL/Lymphoma | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 4 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026